Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results May 14, 2025 07:00AM
Verve Therapeutics (VERV) PT Lowered to $20 at RBC Capital Aug 9, 2024 06:29AM
Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement Dec 1, 2023 04:00PM
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement Nov 28, 2023 10:37PM
Verve Therapeutics (VERV) Announces Proposed Public Offering of Common Stock and Concurrent Private Placement Nov 28, 2023 04:03PM


Nov 28, 2023 04:01PM Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
May 15, 2023 06:31AM Verve Therapeutics (VERV) Reports Q1, Provides Pipeline Progress Update
May 9, 2023 06:30AM Verve Therapeutics to Participate in the RBC Capital Markets 2023 Global Healthcare Conference
May 4, 2022 06:30AM Verve Therapeutics to Participate in Upcoming May Investor Conferences
May 4, 2022 06:30AM Verve Therapeutics to Participate in Upcoming May Investor Conferences
Feb 17, 2022 04:04PM UPDATE: RBC Capital Starts Verve Therapeutics (VERV) at Outperform